Irritable Bowel Syndrome (IBS) - Modern Medicine

ADVERTISEMENT

Irritable Bowel Syndrome (IBS)

Resource Center: Gastroenterology
TOP STORY
Lubiprostone (Amitiza): Chloride channel activator approved for the treatment of irritable bowel syndrome with constipation
New indication: Lubiprostone (Amitiza), a chloride channel activator, was approved on April 29, 2008, for the treatment of irritable bowel syndrome with constipation (IBS-C) in women aged at least 18 years.

ADVERTISEMENT

ADVERTISEMENT

Click here